Jean de Mareuil

Summary

Country: France

Publications

  1. ncbi HIV-1 Tat protein enhances microtubule polymerization
    Jean de Mareuil
    UMR Univ, Med, CNRS FRE 2737, Faculte de Pharmacie, Universite de la Mediterranee, 27 Bd Jean Moulin, 13385 Marseille, France
    Retrovirology 2:5. 2005
  2. ncbi The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis
    Grant R Campbell
    CNRS Formation de Recherche en Evolution 2737, Faculte de Pharmacie, Universite de la Mediterranee, 27, Boulevard Jean Moulin, 13385 Marseille, France
    J Biol Chem 279:48197-204. 2004
  3. ncbi Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine
    Jennifer D Watkins
    UMR Univ, Med, CNRS FRE 2737, Faculte de Pharmacie, Universite de la Mediterranee, 27 Bd Jean Moulin, 13385 Marseille, France
    Retrovirology 3:8. 2006
  4. ncbi Full-length HIV-1 Tat protein necessary for a vaccine
    Sandrine Opi
    CNRS FRE 2737, , 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France
    Vaccine 22:3105-11. 2004

Detail Information

Publications4

  1. ncbi HIV-1 Tat protein enhances microtubule polymerization
    Jean de Mareuil
    UMR Univ, Med, CNRS FRE 2737, Faculte de Pharmacie, Universite de la Mediterranee, 27 Bd Jean Moulin, 13385 Marseille, France
    Retrovirology 2:5. 2005
    ..We compared the effect on tubulin polymerization of these Tat variants and peptides corresponding to different parts of the Tat sequence, with paclitaxel, an anti-cancer drug that targets microtubules...
  2. ncbi The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis
    Grant R Campbell
    CNRS Formation de Recherche en Evolution 2737, Faculte de Pharmacie, Universite de la Mediterranee, 27, Boulevard Jean Moulin, 13385 Marseille, France
    J Biol Chem 279:48197-204. 2004
    ..The glutamine-rich region of Tat appears to be involved in the Tat-mediated apoptosis of T-cells...
  3. ncbi Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine
    Jennifer D Watkins
    UMR Univ, Med, CNRS FRE 2737, Faculte de Pharmacie, Universite de la Mediterranee, 27 Bd Jean Moulin, 13385 Marseille, France
    Retrovirology 3:8. 2006
    ..A formulation was tested on macaques followed by a SHIV challenge with a European strain...
  4. ncbi Full-length HIV-1 Tat protein necessary for a vaccine
    Sandrine Opi
    CNRS FRE 2737, , 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France
    Vaccine 22:3105-11. 2004
    ..We suggest that a Tat vaccine should contain a Tat variant with regular size, up to 99-101 residues now found in the field...